MassBio

Happy Holidays! The MassBio team is sending warm wishes for a holiday season filled with joy, peace, and good health. We're incredibly grateful for our dedicated members, partners, and the entire life sciences community who make our work possible.

Our last #FundingFriday of the year spotlights Portal's $7 million Seed Round led by IA Ventures. Since emerging from stealth a year ago, Portal has accumulated over 50 biopharma and academic partners leveraging the next generation mechanical delivery technology for applications ranging from novel drug screening assays to engineering cell therapies with circular RNA. We also celebrate the launch of Tasca Therapeutics, the first startup created out of Cure Ventures, with a $52M Series A round to develop small molecule inhibitors for multiple oncology indications. #MassBioMembers #PatientDriven

What a fantastic final month of the year in the #MassBioHub! THANK YOU for making the Hub your life sciences event destination in 2024. #HubHappenings #PatientDriven 💥Addgene hosted their annual board workshop 📸Aging Initiative at Harvard and leaders in the aging biology space from greater Boston met for a night of insightful discussion about opportunities, happenings, and the future of the aging biology field 💥The Boston Biotech Forum hosted their Annual Holiday Party: https://lnkd.in/eHXggyyK 📸Cambridge Chamber of Commerce (USA) hosted their Annual Holiday Party 💥Cresset hosted their workshop for computational chemistry, product updates and software demonstrations 💥Cytiva hosted their multi-customer portfolio showcase event 💥Dipharma Inc. hosted a lecture by Peter Wuts, coauthor of the book "Protecting groups in organic synthesis" 📸Latinos in Bio hosted their Holiday Network Fiesta: Celebrating Latino Culture and Community 💥MaxCyte, Inc. and OmniaBio hosted a discussion on Fast Tracking Cell Therapy Development: Intelligent Manufacturing and Reliable Gene Delivery Tools

BioversityMA set out to blaze training pathways and create employer connections for underrepresented and low-income populations. They are now the biggest and most diverse biotech certificate training program in Massachusetts.👏 Read more in this guest blog, "Bioversity’s First Year: A Story of People Making Change for Themselves," from Executive Director Zach Stanley on the impact Bioversity had has this year, and what's next - including a new lab facility in Lowell in partnership with University of Massachusetts Lowell: https://lnkd.in/eEVmcRrR

Our team has been visiting with #MassBioMembers the last few weeks of the year - it's always great to get out and see everyone! 📸November's Lunch and Learn on-site with The Richmond Group 📸Hosting Flagship Lab Services (Flagship Facility Services, Inc.) and Boston Lab Services at the #MassBioHub in November Learn more about the benefits of MassBio membership: https://lnkd.in/e8HkSMyv

What a year it has been - from April’s State of Possible Conference where we heard from Super Bowl champion and advocate Devin McCourty about our industry’s work on sickle cell disease to getting the call that the LSI would be fully funded for the next decade to hearing Joe and Courtney Dion speak about their two children with an ultrarare disease and how their The Dion Foundation has made a gene therapy clinical trial possible in the United States with Atamyo Therapeutics. Read MassBio CEO & President Kendalle Burlin O'Connell, Esq.'s year-end blog for more highlights from this year and what the future holds in 2025: https://lnkd.in/e4sknuvK

For interested companies, the MLSC offers virtual info sessions on eligibility requirements, various tax incentives available, compliance and reporting requirements, application process overview, and timeline for awards. There is a session today (Dec. 18) at 1:00 p.m. and another on Jan 13 at 10:30 a.m. More details: https://lnkd.in/dxE4KJy

The MassBio team will be in San Francisco the week of January 12, 2025, during the J.P. Morgan Healthcare Conference. We look forward to seeing old friends and meeting new partners. Be sure to reach out to say hello to our team! 👋 Chief Operating & Innovation Officer Jason Cordeiro | Chief Business Officer Laura Hamilton | Head of External Affairs Benjamin Bradford | Sr. Director of Innovation Caroline Pepek | Manager of Innovation, Portfolio Nikki Taylor Seiler, MHA Read their bios and view contact info here: https://lnkd.in/ezmWFmmg #JPM2025

As we quickly approach the end of the year, I wanted to share my MassBio Top 10 of 2024 with you. It was tough narrowing it down to just 10 - so many others I could have mentioned - but suffice to say the year was a memorable one. What were your favorite moments? For a more in-depth retrospective, my year end blog is now live: https://lnkd.in/ePH8yfP9. #PatientDriven #MassBioMembers

MassBio and The Termeer Foundation are committed to supporting CEOs, entrepreneurs, and their networks by fostering meaningful connections and collaboration through the CEO & Founder Link. Life sciences company founders and CEOs are invited to apply to join the CEO & Founder Link, where they can attend exclusive quarterly events and enjoy access to premium meeting spaces at major industry conferences, including during the JP Morgan Healthcare Conference. Applications are accepted on a rolling basis - apply today: https://lnkd.in/eGaCewZi